BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28693693)

  • 1. Can Fundus Fluorescein Angiography be Performed for Diabetic Patients on Oral Metformin?
    Du J; Li R
    Chin Med Sci J; 2017 Jun; 32(2):119-2. PubMed ID: 28693693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy.
    Wang J; Ai X; Li L; Gao Y; Sun N; Li C; Sun W
    Int Urol Nephrol; 2017 Nov; 49(11):2019-2026. PubMed ID: 28656510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing nephropathy induced by contrast medium.
    Gross JL; Friedman R; Silveiro SP
    N Engl J Med; 2006 Apr; 354(17):1853-5; author reply 1853-5. PubMed ID: 16641408
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nephrotoxicity due to iodine contrasts in computerized tomography studies of diabetic outpatients on metformin].
    Gómez Herrero H; De Arriba Villamor C; Buldain Parra M; Arraiza Sarasa M
    An Sist Sanit Navar; 2013 Sep; 36(2):197-201. PubMed ID: 24008523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are patients with mild to moderate renal impairment on metformin or other oral anti-hyperglycaemic agents at increased risk of contrast-induced nephropathy and metabolic acidosis after radiocontrast exposure?
    Jung J; Cho YY; Jung JH; Kim KY; Kim HS; Baek JH; Hahm JR; Cho HS; Kim SK
    Clin Radiol; 2019 Aug; 74(8):651.e1-651.e6. PubMed ID: 31202566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral fluorescein angiography with the scanning laser ophthalmoscope in diabetic retinopathy: a case controlled comparison with intravenous fluorescein angiography.
    Squirrell D; Dinakaran S; Dhingra S; Mody C; Brand C; Talbot J
    Eye (Lond); 2005 Apr; 19(4):411-7. PubMed ID: 15184968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin: a biguanide.
    Tanja JJ; Langlass TM
    Diabetes Educ; 1995; 21(6):509-10, 513-4. PubMed ID: 8549253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and contrast-induced acute kidney injury in diabetic patients treated with primary percutaneous coronary intervention for ST segment elevation myocardial infarction: Amulticenter study.
    Zeller M; Labalette-Bart M; Juliard JM; Potier L; Feldman LJ; Steg PG; Cottin Y; Roussel R
    Int J Cardiol; 2016 Oct; 220():137-42. PubMed ID: 27376570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes and metformin. First choice for monotherapy: weak evidence of efficacy but well-known and acceptable adverse effects.
    Prescrire Int; 2014 Nov; 23(154):269-72. PubMed ID: 25954799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of fundus photography and fluorescein angiography in grading diabetic retinopathy].
    Gao LQ; Zhang F; Zhou HY; Yan W; Xiong Y; Wang GL
    Zhonghua Yan Ke Za Zhi; 2008 Jan; 44(1):12-6. PubMed ID: 18510235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of oral fluorescein angiography in the diagnosis of macular oedema within a diabetic retinopathy screening programme.
    Razvi FM; Kritzinger EE; Tsaloumas MD; Ryder RE
    Diabet Med; 2001 Dec; 18(12):1003-6. PubMed ID: 11903401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New contraindication to intravascular iodinated contrast material.
    Dachman AH
    Radiology; 1995 Nov; 197(2):545. PubMed ID: 7480710
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of metformin with intravenous iodinated contrast media and precautions.
    Shah MA; Niazi SG; Tahir IM; Shahid I; Parveen A; Sana S; Akhter N; Iftikhar N; Ashraf S; Siddique Z; Mushtaq Y; Khan M; Akram M
    Pak J Pharm Sci; 2019 Mar; 32(2 (Supplementary)):859-863. PubMed ID: 31103983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What every dentist should know about metformin, diabetes, and cancer.
    Frykenberg MR; Schneider A; Bashirelahi N
    Gen Dent; 2015; 63(5):70-2. PubMed ID: 26325646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin, a promising oral antihyperglycemic for the treatment of noninsulin-dependent diabetes mellitus.
    Wildasin EM; Skaar DJ; Kirchain WR; Hulse M
    Pharmacotherapy; 1997; 17(1):62-73. PubMed ID: 9017766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of oral fluorescein angiography using the confocal scanning laser ophthalmoscope and digital fundus camera with intravenous fluorescein angiography using the digital fundus camera.
    Azad RV; Baishya B; Pal N; Sharma YR; Kumar A; Vohra R
    Clin Exp Ophthalmol; 2006 Jul; 34(5):425-9. PubMed ID: 16872337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin: the past, presence, and future.
    Alušík Š; Paluch Z
    Minerva Med; 2015 Aug; 106(4):233-8. PubMed ID: 25532538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Suggestions for prevention of adverse reactions after intravasal administration of iodinated contrast media].
    Kuefner MA; Heinrich M; Bautz W; Uder M
    Rontgenpraxis; 2008; 56(6):199-206. PubMed ID: 19294866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New contraindication to intravascular iodinated contrast material.
    Rotter A
    Radiology; 1995 Nov; 197(2):545-6. PubMed ID: 7480711
    [No Abstract]   [Full Text] [Related]  

  • 20. Which oral agent to use when metformin is no longer effective?
    Bannon M
    QJM; 2011 Mar; 104(3):183-4. PubMed ID: 21330402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.